2007: RA: Clinical Aspects II
Search or Browse by Day

RA: Clinical Aspects II

976
Cause Specific Mortality in Patients Receiving Anti-TNF Therapy for Rheumatoid Arthritis: Results from the British Society for Rheumatology Biologics Register (BSRBR)
977
Adverse Socioeconomic Circumstances Need Not Prejudice Rheumatoid Arthritis (RA) Outcomes: Results of a 5 Year Prospective Study
978
Prediction of Mortality Over 5-20 Years in 210 Patients with Rheumatoid Arthritis From 1985-2005 According to a Multidimensional Health Assessment Questionnaire (MDHAQ), Swollen Joint Counts with 28, 42 or 66 Joints, Age and Gender
979
Gender Differences in Outcome at 5 Years: Results from a Prospective Disease Modifying Therapy Study in Rheumatoid Arthritis
980
Women Have a More Severe Disease Than Men when Starting Their First Biological Treatment for RA
981
Does Vitamin D Level Influence RA Disease Activity and Function?
982
The Impact of Total Knee Replacement (TKR) on Patient Reported Pain and Health-Related Quality of Life in Subjects with Rheumatoid Arthritis (RA)
983
Large Joint Replacements and Arthrodeses in RA Patients Followed over 20 Years- Prevalence and Predictive Factors
984
Determinants of Mortality Risk among Males with Rheumatoid Arthritis
985
Lung Cancer after Exposure to Disease Modifying Anti-Rheumatic Drugs
986
Hematological Malignancies after Drug Exposure in Rheumatoid Arthritis
987
Increasing RA Severity and Disease Comorbidities Are Associated with Decreasing Hemoglobin in the CORRONA Database
988
Anemia is an Independent Factor Associated with Physical Disability among Patients with Rheumatoid Arthritis
989
A Review of Lymphoma Occurring in Rheumatoid Arthritis Patients in the Consortium of Rheumatology Researchers of North America (CORRONA) Database
990
Female is a Risk Factor for Develolping AA-Amyloidosis in patients with Rheumatoid Arthritis
991
Incidence of Adverse Effects During Long-Term, Low-Dose Glucocorticoid Treatment of Rheumatoid Arthritis
992
Glucocorticoid Treatment is Associated with Increased Insulin Resistance in Subjects with Rheumatoid Arthritis (RA)
993
High Disease Activity Burden Predicts Severe Extra-Articular Manifestations in Early Rheumatoid Arthritis
994
Incidence of Malignancies in Japanese Rheumatoid Arthritis Patients in an Observational Cohort IORRA in Comparison to the Japanese Population Database
995
High Disease Activity is not an Additional Risk Factor for Myocardial Infarction in Rheumatoid Arthritis
996
Body Composition is Associated with Radiographic Damage in Rheumatoid Arthritis
997
Central Obesity is Increased in Men with Rheumatoid Arthritis (RA) and is Associated with Insulin Resistance (IR) and Subclinical Coronary Atherosclerosis
998
Rheumatoid Arthritis (RA) Modifies the Atherogenic Effect of Traditional Cardiovascular (CV) Risk Factors
999
The Influence of Social Deprivation on Cardiovascular Risk Factors in a Cohort of Female Rheumatoid Arthritis Patients Living in an Inner City Area: The Value of the ASSIGN Score in Predicting Ten Year Risk
1000
Nodules and Rheumatoid Factor Status Both Independently Predict Early and Late Cardiovascular Disease Mortality in Inflammatory Polyarthritis: Results from a Primary-Care Based Cohort
1001
Pro-inflammatory High-Density Lipoprotein (HDL) is Associated with Poor Disease Control and Increased Haptoglobin Content of HDL in Patients with Rheumatoid Arthritis
1002
Vascular Endothelial Function is Related to Endothelial Biomarkers in Early RA
1003
Significant Increase of Intima Media Thickness in Only Eighteen Months among Patients with Early RA
1004
Management and Treatment of Heart Failure among Rheumatoid Arthritis Subjects Compared to Non-RA Subjects
1005
Early Treatment Reduce the Cardiovascular Risk in Newly Diagnosed Rheumatoid Arthritis Patients
1006
Progression of Cardiovascular Co-Morbidity in Early RA
1007
Decreased Prevalence of the Metabolic Syndrome in Rheumatoid Arthritis
1008
Prevalence of the Metabolic Syndrome in U.S. Veterans with Rheumatoid Arthritis
1009
Whole Body Composition Assesment by Dual Energy X-Ray Absorptiometry in Rheumatoid Arthritis
1010
No Evidence for Increased Common Carotid Artery Intima-Media Thickness in Patients with Severe Extra-articular Rheumatoid Arthritis
1011
HLA-DRB1*04 and HLA-C3 Associations with Extra-Articular Manifestations in Rheumatoid Arthritis are Not Explained by Linkage Disequilibrium with TNFA Alleles
1012
High Prevalence of Carotid Plaques in Rheumatoid Arthritis Iis not Associated with Autoantibodies
1013
Increase of Body Fat Mass in Rheumatoid Arthritis is Not Explained by Dietary Calorie Intake
1014
Prevalence of Cardiovascular Risk Factors in Patients with Rheumatoid Arthritis
1015
Prevalence of Traditional and Non-Traditional Cardiovascular Risk Factors in Rheumatic Diseases
1016
Incidence of Interstitial Pneumonitis in RA Patients Based on the Large Observational Cohort Study IORRA in Japan
1017
High Prevalence of Moderate to Severe Periodontal Disease in Rheumatoid Arthritis Patients
1018
Rheumatoid Arthrits and Sarcopenia: Determinants Factors
1019
Bone Loss in Early Rheumatoid Arthritis after Two Years of Follow up
1020
Prevalence of Vertebral Fractures in Elderly Patients with Early Rheumatoid Arthritis
1021
Divergent Results of Screening Tests for M.tuberculosis Infection among Candidates for Anti-TNF Therapy Call for New Screening Guidelines
1022
Tuberculosis Incidence Low in Double-Blind and Open-Label Etanercept Studies in Patients With Rheumatoid Arthritis
1023
Extended Follow-up of Patients with at Positive Tuberculin Skin Test Treated With Etanercept
1024
Drug-Specific, Time-Dependent Risks of Serious Bacterial Infections Associated with TNF-α Antagonists
1025
The effect of Infliximab and timing of vaccination on the humoral response to influenza vaccination in patients with Rheumatoid Arthritis and Ankylosing Spondylitis.
1026
Immune Response to Pneumococcal Vaccine in Patients with Rheumatoid Arthritis under IL-6 Receptor Inhibition Therapy with Tocilizumab
1027
Role of Quantiferon-Tb Gold Test in the Identification of Latent Tuberculosis Infection in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis
1028
The Use of the T-spot.TB Test to Diagnose Latent Tuberculosis Infection (LTBI) in Rheumatic Disease Patients on Immunosuppressive Therapy
1029
Late Tuberculosis in Patients with Rheumatoid Arthritis and Anti-tnf Alfa Therapy. Four Cases in a Single Center
1030
Screening of Mycobacterium Tuberculosis by Immunological Diagnosis Using ELISPOT Technique before Anti-TNF Therapy
1031
Comparison of Tuberculin Skin Test and Quantiferon®-TB Gold Test in Patients with Rheumatoid Arthritis Living in a Tuberculosis Endemic Population
1032
Whole Blood Interferon-Gamma Assay is Useful to Assess the Risk of Latent Tuberculosis Infection in Patients with Rheumatoid Arthritis
1033
Definitive Results of the National French Prospective RATIO 3-Year Observatory on Tuberculosis in Patients Treated with TNF Blockers: The Risk Persists but Depends on the Drug
1034
Diverticular Disease in Rheumatoid Arthritis
1035
Small Bowel Enteropathy in Rheumatoid Arthritis - Capsule Endoscopy Study in Anemic Rheumatoid Arthritis Patients
1036
Epidemiology of Major Depression in Japanese Patients with Rheumatoid Arthritis Using Mini-International Neuropsychiatric Interview (MINI)
1037
Does Depression Influence Self-Reported Disability in RA? Evidence of a Gender Effect
1038
Prevalence Of Vertebral Ankylosis In Patients With Rheumatoid Arthritis And Symptomatic Involvement Of The Cervical Spine.
1039
Descriptive Trend Analysis of Infections and Malignancies in the Abatacept Clinical Development Program
See more of: ACR Abstract Submission Poster Sessions
<< Previous Session Level | Next Session Level >>